Exodus Point Capital Management, LP Codexis, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $212,539 - $341,261	-49,892 Reduced 53.75%	42,922 $200,000
Q3 2022 Nov 10, 2022	BUY	$6.06 - $12.86 $9,483 - $20,125	1,565 Added 1.72%	92,814 $562,000
Q2 2022 Aug 19, 2022	BUY	$8.35 - $21.89 $620,338 - $1.63 Million	74,292 Added 438.12%	91,249 $954,000
Q1 2022 May 13, 2022	BUY	$16.97 - $31.93 $287,760 - $541,437	16,957 New	16,957 $350,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $41.78 $398,901 - $650,765	-15,576 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $306,068 - $435,972	15,576 New	15,576 $362,000
Q1 2020 May 15, 2020	SELL	$8.78 - $18.6 $117,836 - $249,630	-13,421 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.12 - $17.06 $176,083 - $228,962	13,421 New	13,421 $215,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $167M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.